ZA987676B - 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors and intermediates thereof - Google Patents
3-amidinoaniline derivatives activated blood coagulation factor X inhibitors and intermediates thereofInfo
- Publication number
- ZA987676B ZA987676B ZA987676A ZA987676A ZA987676B ZA 987676 B ZA987676 B ZA 987676B ZA 987676 A ZA987676 A ZA 987676A ZA 987676 A ZA987676 A ZA 987676A ZA 987676 B ZA987676 B ZA 987676B
- Authority
- ZA
- South Africa
- Prior art keywords
- intermediates
- inhibitors
- blood coagulation
- coagulation factor
- activated blood
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27185397 | 1997-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA987676B true ZA987676B (en) | 1999-02-25 |
Family
ID=17505799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA987676A ZA987676B (en) | 1997-08-27 | 1998-08-25 | 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors and intermediates thereof |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1020434A4 (fr) |
KR (1) | KR20010023364A (fr) |
CN (1) | CN1268116A (fr) |
AR (1) | AR016868A1 (fr) |
AU (1) | AU8747598A (fr) |
CA (1) | CA2301559A1 (fr) |
CO (1) | CO4970693A1 (fr) |
IL (1) | IL134394A0 (fr) |
PE (1) | PE107999A1 (fr) |
WO (1) | WO1999010316A1 (fr) |
ZA (1) | ZA987676B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6545055B1 (en) | 1999-05-24 | 2003-04-08 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
EP1183235A2 (fr) | 1999-05-24 | 2002-03-06 | Cor Therapeutics, Inc. | INHIBITEURS DU FACTEUR Xa |
DE10041402A1 (de) * | 2000-08-23 | 2002-03-14 | Morphochem Ag | Neue Verbindungen, die Faktor Xa-Aktivität inhibieren |
EP1095933A1 (fr) * | 1999-10-30 | 2001-05-02 | Aventis Pharma Deutschland GmbH | N-guanidinoalkylamides, procédé de leur préparation, leur utilisation et compositions pharmaceutiques les contenant |
US20020065303A1 (en) * | 2000-02-01 | 2002-05-30 | Bing-Yan Zhu | Bivalent phenylene inhibitors of factor Xa |
WO2001064642A2 (fr) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides et inhibiteurs connexes du facteur xa |
DE10027025A1 (de) * | 2000-05-31 | 2001-12-06 | Merck Patent Gmbh | Clycinamide |
DE10036121A1 (de) * | 2000-07-25 | 2002-02-07 | Merck Patent Gmbh | N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate |
DE10040783A1 (de) | 2000-08-21 | 2002-03-07 | Merck Patent Gmbh | AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) |
DE10050723A1 (de) * | 2000-10-13 | 2002-04-25 | Merck Patent Gmbh | N-Substituierte Aminosäurederivate (Faktor Xa Inhibitoren 12) |
US7312235B2 (en) | 2001-03-30 | 2007-12-25 | Millennium Pharmaceuticals, Inc. | Benzamide inhibitors of factor Xa |
DE10130374A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Substituierte N-Acyl-anilinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
JPWO2003040086A1 (ja) * | 2001-11-09 | 2005-03-03 | キッセイ薬品工業株式会社 | 5−アミジノ−2−ヒドロキシベンゼンスルホンアミド誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体 |
CA2479254A1 (fr) * | 2002-03-22 | 2003-10-02 | Kissei Pharmaceutical Co., Ltd. | Agent preventif ou therapeutique pour nephropathie |
DE10220048A1 (de) * | 2002-05-04 | 2003-11-13 | Merck Patent Gmbh | Semicarbazidderivate |
HUE025683T2 (hu) | 2002-12-03 | 2016-04-28 | Pharmacyclics Llc | VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok |
WO2005034867A2 (fr) | 2003-10-09 | 2005-04-21 | Millennium Pharmaceuticals, Inc. | Utilisation de benzamides a substitution thioether en tant qu'inhibiteurs du facteur xa |
BRPI0512273A (pt) | 2004-06-18 | 2008-02-19 | Millennium Pharm Inc | inibidores do fator xa |
US7329656B2 (en) | 2004-10-08 | 2008-02-12 | H. Lundbeck A/S | Arylthiobenzylpiperidine derivatives |
US7446204B2 (en) | 2004-10-08 | 2008-11-04 | H. Lundbeck A/S | Amino substituted aryloxybenzylpiperidine derivatives |
US20080132507A1 (en) * | 2004-10-13 | 2008-06-05 | Eisai R&D Management Co., Ltd. | Hydrazide Derivatives |
WO2006055951A2 (fr) | 2004-11-19 | 2006-05-26 | Portola Pharmaceuticals, Inc. | Tetrahydroisoquinolines comme inhibiteurs du facteur xa |
WO2006063113A2 (fr) | 2004-12-07 | 2006-06-15 | Portola Pharmaceuticals, Inc. | Urees utilisees comme inhibiteurs du facteur xa |
JP4900238B2 (ja) | 2005-02-02 | 2012-03-21 | 味の素株式会社 | 新規ベンズアミジン化合物 |
CA2627086C (fr) | 2005-11-08 | 2016-04-05 | Millennium Pharmaceuticals, Inc. | Nouveaux sels pharmaceutiques et polymorphes d'un inhibiteur du facteur xa |
ATE557010T1 (de) | 2006-03-24 | 2012-05-15 | Eisai R&D Man Co Ltd | Triazolonderivat |
PT2077995E (pt) | 2006-11-02 | 2012-05-10 | Millennium Pharm Inc | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
WO2009038157A1 (fr) | 2007-09-21 | 2009-03-26 | Eisai R & D Management Co., Ltd. | Dérivé de 2,3-dihydroiminoisoindole |
KR20110036833A (ko) | 2008-07-11 | 2011-04-11 | 아지노모토 가부시키가이샤 | 아미딘 유도체 |
EA015918B1 (ru) | 2010-03-03 | 2011-12-30 | Дмитрий Геннадьевич ТОВБИН | УРЕТАНЫ, МОЧЕВИНЫ, АМИДЫ И РОДСТВЕННЫЕ ИНГИБИТОРЫ ФАКТОРА Xa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2606643B2 (ja) * | 1992-04-01 | 1997-05-07 | 日東紡績株式会社 | 安息香酸アミジノフェニルエステル誘導体 |
JPH07330695A (ja) * | 1994-04-11 | 1995-12-19 | Green Cross Corp:The | 新規カルボン酸誘導体またはその塩、およびその医薬用途 |
PT892780E (pt) * | 1996-02-22 | 2003-02-28 | Bristol Myers Squibb Pharma Co | Analogos de m-amidino fenilo como inibidores do factor xa |
JPH101467A (ja) * | 1996-06-13 | 1998-01-06 | Banyu Pharmaceut Co Ltd | ビフェニルアミジン誘導体 |
-
1998
- 1998-08-20 KR KR1020007002002A patent/KR20010023364A/ko not_active Application Discontinuation
- 1998-08-20 EP EP98938906A patent/EP1020434A4/fr not_active Withdrawn
- 1998-08-20 AU AU87475/98A patent/AU8747598A/en not_active Abandoned
- 1998-08-20 WO PCT/JP1998/003685 patent/WO1999010316A1/fr not_active Application Discontinuation
- 1998-08-20 IL IL13439498A patent/IL134394A0/xx unknown
- 1998-08-20 CA CA002301559A patent/CA2301559A1/fr not_active Abandoned
- 1998-08-20 CN CN98808582A patent/CN1268116A/zh active Pending
- 1998-08-25 AR ARP980104195A patent/AR016868A1/es unknown
- 1998-08-25 PE PE1998000777A patent/PE107999A1/es not_active Application Discontinuation
- 1998-08-25 ZA ZA987676A patent/ZA987676B/xx unknown
- 1998-08-26 CO CO98048593A patent/CO4970693A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU8747598A (en) | 1999-03-16 |
CO4970693A1 (es) | 2000-11-07 |
CN1268116A (zh) | 2000-09-27 |
IL134394A0 (en) | 2001-04-30 |
KR20010023364A (ko) | 2001-03-26 |
EP1020434A4 (fr) | 2000-11-15 |
WO1999010316A1 (fr) | 1999-03-04 |
PE107999A1 (es) | 1999-11-24 |
EP1020434A1 (fr) | 2000-07-19 |
AR016868A1 (es) | 2001-08-01 |
CA2301559A1 (fr) | 1999-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA987676B (en) | 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors and intermediates thereof | |
HUP9800634A3 (en) | P-amidino-benzylamide derivatives as thrombin inhibitors, intermediates and use thereof | |
EP0983482A4 (fr) | Appareil de cartographie vasculaire et son procede d'utilisation | |
IL135008A0 (en) | Expandable ligator catheter having multiple electrode leads, and method of use | |
EP1024130A4 (fr) | Derives de biphenyl-5-acide alcanoique et leurs applications | |
HUP0002493A3 (en) | Use of colchinol derivatives as vascular damaging agents and certain new compounds | |
HUP9700602A3 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
AU7250098A (en) | Anastomosis system and method of use | |
IL122186A (en) | Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists | |
PL350822A1 (en) | Disposable wiper-cloth and method of making same | |
EP0831800A4 (fr) | DERIVES D'ARYLSULFONYLAMINOBENZENE ET LEUR UTILISATION COMME INHIBITEURS DU FACTEUR Xa | |
HK1023832A1 (en) | Clinical and/or surgical training apparatus | |
HUP0104500A3 (en) | Thrombin inhibitor dipeptide derivatives and their use | |
IL122813A0 (en) | Thrombin inhibitors their preparation and use | |
IL133490A0 (en) | New amidino derivatives and their use as thrombin inhibitors | |
AU4717301A (en) | Catheter assembly and method of use | |
PL350826A1 (en) | Disposable wiper-cloth and method of making same | |
IL126093A0 (en) | Promotion of regeneration of organized tissues | |
AU4204697A (en) | Tetrahydroisoquinoline derivatives and their pharmaceutical use | |
AU8662198A (en) | Activated forms of notch and methods based thereon | |
AU7277598A (en) | Energy delivery of catheter and method for the use thereof | |
ZA983065B (en) | Inhibitors of protein farnesyltranferase | |
NO994736D0 (no) | FremgangsmÕte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU6120298A (en) | 2-peperazinone-1-acetic acid derivatives and their use |